Company Overview
SUPERNUS PHARMACEUTICALS, INC.
SUPNRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
719M
2025 FY
Net Income
-39M
2025 FY
Shares Outstanding
56M
2025 FY
EPS
-0.68USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1356576
Exchange
Nasdaq
Location
US